Fragmin (Pfizer Laboratories Div Pfizer Inc)


Welcome to the PulseAid listing for the Fragmin drug offered from Pfizer Laboratories Div Pfizer Inc. This Anti-coagulant [EPC],Heparin, Low-Molecular-Weight [Chemical/Ingredient],Low Molecular Weight Heparin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Pfizer Laboratories Div Pfizer Inc
NON-PROPRIETARY NAME: Dalteparin Sodium
SUBSTANCE NAME: DALTEPARIN SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anti-coagulant [EPC],Heparin, Low-Molecular-Weight [Chemical/Ingredient],Low Molecular Weight Heparin [EPC]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-04-01
END MARKETING DATE: 0000-00-00


Fragmin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFragmin from Pfizer Laboratories Div Pfizer Inc
LABELER NAME: Pfizer Laboratories Div Pfizer Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 2500([iU]/.2mL)
START MARKETING DATE: 2015-04-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0069-0195_35ed2da4-58fb-44ae-ae4d-13769110c855
PRODUCT NDC: 0069-0195
APPLICATION NUMBER: NDA020287

Other DALTEPARIN SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Pfizer Laboratories Div Pfizer IncFragmin